ArticleScientific reports2026
FT-MDNNMDs: early detection of breast cancer using fine-tuned multi-deep neural networks with TCGA and clinical image datasets.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Breast cancer remains one of the leading causes of cancer-related mortality among women worldwide. Early and accurate detection is critical for improving survival rates and enabling effective treatment. This research proposes a fine-tuned Multi-Deep Neural Network model with Multiple Datasets (FT-MDNNMDs). The proposed system employs a hierarchical classification strategy, first distinguishing cancer from normal cases, and subsequently classifying cancer-positive cases into Stage II and Stage III categories. The model integrates data from The Cancer Genome Atlas (TCGA) and a private clinical image dataset collected from hospitals in Pakistan. Preprocessing techniques, including image normalization, filtering, and Principal Component Analysis (PCA), are applied to enhance feature quality and reduce redundancy. Transfer learning and fine-tuning strategies are incorporated to further improve classification performance. The proposed model effectively distinguishes between benign and malignant tumors and accurately identifies stage II and stage III cases. Experimental results demonstrate that the fine-tuned MDNNMDs model achieves an accuracy of 99.57%, outperforming conventional machine learning algorithms such as Support Vector Machine (94.46%), Decision Tree (93.54%), and Naïve Bayes (91.22%). The model also achieved superior MCC (99.46%), F-score (99.57%), and recall (99.63%). In addition to algorithmic comparison, the performance of the proposed model is compared with existing breast cancer detection models, and it is revealed that the proposed model provides more accurate results than existing ones, with 1.5% to 3.0% better accuracy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.